Agendia Login

Home | Agendia

A breast cancer diagnosis can often mean you are faced with many difficult and unanswered questions. Do I need chemotherapy? What are my options? Can I benefit from a less radical treatment strategy? At Agendia, we believe it’s our collective responsibility to help ease this anxiety with breakthrough genomic testing for breast cancer.

https://www.agendia.com/

Ordering portal | Agendia

If you’re having trouble logging in. Please contact our Customer Care team and they will gladly assist you. (888) 321-2732 or [email protected]

https://www.agendia.com/ordering-portal/

Reporting & Ordering | Agendia

Important ordering information. MammaPrint can be ordered alone or in combination with BluePrint. BluePrint is not available independently. MammaPrint is available for any patient who meets its eligibility criteria, even if a patient has already had another type of genomic test.

https://www.agendia.com/our-tests/how-to-order

Our tests | Agendia

Agendia’s genomic tests for women with breast cancer leverage deep science to analyze the genes within the tumor, assessing the risk of breast cancer rec. Agendia’s genomic tests for women with breast cancer leverage deep science to analyze the genes within the tumor, assessing the risk of breast cancer rec. …

https://www.agendia.com/our-tests/

Login

Maintenance Notice: ©

https://etelenext.xifin.net/Agendia/apvx/Workflow/Worklist2.aspx

MammaPrint – Wikipedia

MammaPrint is a prognostic and predictive diagnostic test for early stage breast cancer patients that assess the risk that a tumor will metastasize to other parts of the body. It gives a binary result, high-risk or low-risk classification, and helps physicians determine whether or not a patient will benefit from chemotherapy.Women with a low risk result can safely forego chemotherapy without …

https://en.wikipedia.org/wiki/Agendia

MammaPrint Test | Agendia

MammaPrint: a test to predict risk of breast cancer recurrence. MammaPrint analyzes the 70 most important genes associated with breast cancer recurrence to classify each breast cancer patient into “Low Risk” or “High Risk” of developing metastases within the first 10 years after diagnosis—without the ambiguity associated with “intermediate” scores found in some other tests.

https://www.agendia.com/our-tests/mammaprint/

Agendia Inc. – Home | Facebook

Agendia Inc., Irvine, CA. 9,127 likes · 25 talking about this. We specialize in best-in-class precision oncology tests that help patients and their physicians make informed personalized treatment…

https://business.facebook.com/AgendiaInc/

Agendia – Home | Facebook

Agendia. 14 likes. Tus reservas en un sólo lugar, las 24 hs. Facebook is showing information to help you better understand the purpose of a Page.

https://www.facebook.com/agendia.co/

Agendia | Breast Cancer Diagnosis Treatment

About Agendia. Agendia is a leading molecular diagnostic company that develops and markets FFPE-based genomic diagnostic products, which help support physicians with their complex treatment decisions. Agendia’s breast cancer Symphony suite was developed using unbiased gene selection, analyzing the complete human genome, ensuring 100% definitive results for cancer patients.

http://www.mammaprint.com.au/agendia/

Leave a Reply